Gesundheits-Aktien — der YouTuber-Konsens
Welche Gesundheits- und Biotech-Aktien empfehlen Finanz-YouTuber mit echter Analyse? Diese Liste ordnet den Konsens der Branche.
ITIntegrys23“The YouTuber recommends Integrys for its supply of ultra-pure chemicals and materials essential for advanced c…”
ADADPT20“The YouTuber identifies Adaptive Biotech Technologies (ADPT) as a potential 10x stock by 2030, based on a patt…”
HIHims & Hers18“The YouTuber argues that Hims is significantly undervalued, trading at 13 times free cash flow while growing r…”
TX10X Genomics17“The YouTuber is highly excited about 10X Genomics, a leader in spatial biology that allows scientists to under…”
CMCompass Pathways16“The YouTuber suggests buying Compass Pathways as a calculated speculation due to its potential for significant…”
ABAbbott Laboratories15“The YouTuber suggests Abbott Laboratories as a potential long-term dividend stock. They note its fair financia…”
ATATAI Life Sciences8“The YouTuber recommends ATAI Life Sciences as a 'diversified play' in the psychedelic therapy market. Unlike C…”
GHGH Research7“The YouTuber suggests GH Research as a 'technology bet' in the psychedelic therapy sector, focusing on a compo…”
“The analyst sees tremendous upside potential in Owlet, despite its high-risk profile and recent CEO change. He…”
ISIntuitive Surgical2“The YouTuber suggests reconsidering Intuitive Surgical, highlighting its strong moat primarily from high switc…”
TOTopicus1“The YouTuber highly recommends Topicus, citing its high growth rates, shareholder-friendly approach (no stock-…”
NVNovo Nordisk1“The YouTuber argues Novo Nordisk is historically cheap despite recent negative sentiment due to lowered guidan…”
“The YouTuber argues that Novo Nordisk is significantly undervalued, trading at half the market's price-to-five…”
BSBoston Scientific0“The YouTuber identifies Boston Scientific as a pure Tier 1 robotics company, building physical systems for med…”
ALAlign Technologies0“The YouTuber suggests Align Technologies is a buy due to its current undervaluation, trading at a P/E of aroun…”
CHChemed0“The YouTuber recommends Chemed as a buy, noting its current P/E of 20 is significantly below its historical av…”
SASanofi0“The YouTuber believes Sanofi is a good buying opportunity due to its current undervaluation, evidenced by a lo…”
PFPfizer0“The YouTuber suggests Pfizer is a buy due to its current low valuation (P/E of 12.99, P/B of 1.57) after a sig…”
CNCentene0“The YouTuber identifies Centene as the cheapest stock in the healthcare insurance sector based on his 'value r…”
SMSara Medtec Ter SMTI0“Adriconomics is buying SMTI, a micro-cap healthcare company focused on wound care, because his custom 'value r…”
ELElevance0“The YouTuber states that Elevance is 'extremely cheap' with a value ratio under 10, suggesting it is a good in…”
CLColoplast0“The analyst suggests Coloplast is an interesting value due to its significant price drop, currently trading 40…”
EXExelixis0“The YouTuber intends to build a small position in Exelixis due to its strong position in the oncology market, …”
DXDexcom0“The analyst views Dexcom as a potential bargain after a significant stock drop due to a lowered outlook, which…”
LNLanthus Holdings INC0“The YouTuber suggests Lanthus Holdings is an interesting and potentially cheap stock, trading at a price to fr…”
POInsulet0“The YouTuber sees Insulet as a good entry opportunity despite recent pressure from weight-loss drugs, arguing …”
JNJohnson and Johnson0“The YouTuber highlights Johnson & Johnson as a strong performer within the healthcare sector during past marke…”
WBWalgreens0“The YouTuber advises investors to continue avoiding Walgreens, labeling it a 'value trap.' He argues that Amaz…”
IQIQVIA0“The YouTuber suggests IQVIA, trading 42.5% below its recent high, as a buy. The company is a market leader in …”
VHVanguard Healthcare ETF0“The YouTuber recommends the Vanguard Healthcare ETF (VHT) for diversification within the healthcare sector. Th…”
XLHealthcare Select Sector SPDR fund0“The YouTuber suggests the Healthcare Select Sector SPDR fund (XLV) as a defensive investment, arguing that peo…”
HCHCA Healthcare0“The YouTuber sees a good opportunity to buy HCA Healthcare, a leading US healthcare provider, due to its stron…”
ABAbbVie0“The YouTuber recommends AbbVie, a global biopharmaceutical company, due to its focus on innovative therapies l…”
VKViking Therapeutics0“The YouTuber is buying Viking Therapeutics, a biopharmaceutical company with promising GLP-1 drugs in trials f…”
SMSummit Therapeutics0“The YouTuber sees Summit Therapeutics as a speculative buy due to its promising cancer drug for non-small cell…”
OWOwlette0“The YouTuber is holding Owlet, a small-cap company with significant share appreciation. He highlights its baby…”
IDIDEX Laboratories0“The YouTuber purchased IDEX Laboratories, a device manufacturer for animal health (livestock and pets). He not…”
DODocimity0“The YouTuber finds Docimity, a niche messaging app for doctors, 'interesting' due to its impressive functional…”
CVCVS0“The YouTuber owns a small piece of CVS, having initially liked its merger with Aetna. He believes they haven't…”
BMBiomerica Inc.0“The YouTuber identifies Biomerica as a potential 'hidden gem' in advanced diagnostics for gastrointestinal dis…”
Noch keine Daten — der Crawler läuft.
Warum du dem Ranking vertrauen kannst
Kein Hype, keine Rosinenpickerei — nur qualifizierte Einschätzungen, gleich gewichtet über alle getrackten Kanäle.Nur qualifizierte Einschätzungen
Eine genannte Aktie, eine klare Kauf- oder Verkaufshaltung und echte Begründung. Beiläufige Erwähnungen und Hype werden herausgefiltert.
Eine Stimme pro Kanal
Jeder Kanal zählt einmal pro Aktie — so kann eine einzelne laute Stimme das Ranking nicht verzerren.
Gewichteter Konsens
Wir gewichten, wie viele Kanäle übereinstimmen, wie überzeugt sie sind und wie aktuell jede Einschätzung ist.
Häufige Fragen
Wie entsteht das Ranking?
Wir crawlen Finanz-YouTuber, transkribieren ihre Videos und extrahieren per KI nur qualifizierte Analysen (genannte Aktie + klare Richtung + echte Begründung). Pro Kanal zählt eine Stimme je Aktie; das Ranking gewichtet Konsens, Analysequalität, Konviktion und Aktualität.
Was zählt als qualifiziertes Signal?
Eine genannte Aktie, eine klare Kauf- oder Verkaufshaltung und echte Begründung — Bewertung, Fundamentaldaten, ein Katalysator oder ein charttechnisches Setup. Beiläufige Erwähnungen ohne Argument werden ignoriert.
Wie oft werden die Daten aktualisiert?
Wir crawlen die getrackten Finanz-YouTuber täglich, transkribieren neue Videos und gewichten das Ranking jeden Tag neu — so rücken die aktuellsten Analysen mit der höchsten Konviktion nach oben.
Ist YouTuberStocks kostenlos?
Ja — komplett kostenlos, und jedes Signal verlinkt auf das ursprüngliche Video als Quelle.
Ist das eine Anlageberatung?
Keine Anlageberatung. Diese Seite bündelt Meinungen Dritter (Finanz-YouTuber) zu Informationszwecken. Triff keine Anlageentscheidung allein auf dieser Basis.